文献速递先天性心脏病外科

杂交姑息治疗:综合二期手术后的结局

Hybrid Palliation: Outcomes After the Comprehensive Stage 2 Procedure.
PubMed 文献 · Ann Thorac Surg · 2017-12-19

基于胸外科医师学会先天性心脏病手术数据库2010至2016年数据,纳入49个中心209例以综合二期手术(CS2)作为索引手术的单心室生理患者,总体手术死亡率为12.4%(26/209)。非存活者术后主要并发症发生率高于存活者(53.9% vs 23.0%,p<0.01),包括肾衰竭和术后体外膜肺氧合使用。作者认为CS2手术死亡率较高,尤其术后需体外膜肺氧合支持者,未发现明显的可干预变量。

要点

  • CS2术后总体手术死亡率为12.4%(26/209)。
  • 非存活者术后主要并发症发生率53.9%,高于存活者的23.0%(p<0.01)。
  • 非存活者术后体外膜肺氧合使用率46.2%,高于存活者的2.7%(p<0.01)。

核心结论

  • CS2手术相关死亡率较高,尤其是CS2术后接受体外膜肺氧合支持的患者。
  • 死亡患者与存活患者之间未发现明显的可干预变量。

研究设计与样本

  • 回顾性分析胸外科医师学会先天性心脏病手术数据库2010至2016年数据。
  • 纳入49个中心209例以CS2作为索引手术的患者,其中141例诊断为左心发育不良综合征。
  • 按手术死亡(院内或术后30天内)分层,采用χ2、Fisher精确检验或Wilcoxon秩和检验进行单因素比较。

主要发现

  • 总体手术死亡率为12.4%(26/209)。
  • 存活者术前体外膜肺氧合使用率为0.0%,非存活者为7.7%(p=0.02)。
  • 存活者同期行三尖瓣手术的比例为1.1%,非存活者为11.5%(p=0.01)。
  • 非存活者术后6项胸外科医师学会先天性心脏病手术数据库主要并发症中任一并发症的发生率为53.9%,存活者为23.0%(p<0.01)。
  • 非存活者术后肾衰竭发生率为7.7%,存活者为0.6%(p=0.04);非存活者术后体外膜肺氧合使用率为46.2%,存活者为2.7%(p<0.01)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The comprehensive stage 2 procedure (CS2) follows initial hybrid stage 1 palliation for patients with single-ventricle physiology. The goal of this study was to describe CS2 outcomes and differences between survivors of CS2 (s-CS2) and nonsurvivors (nons-CS2). METHOD: All patients in The Society of Thoracic Surgeons Congenital Heart Surgery Database who underwent CS2 as index operation from 2010 to 2016 were included. Preoperative, operative, and postoperative data were analyzed, stratified by operative mortality (in-hospital or within 30 days of the operation), with univariate comparisons using χ2, Fisher exact, or Wilcoxon rank sum tests. RESULTS: Of 209 patients (49 centers) who met inclusion criteria, 141 patients had the diagnosis of hypoplastic left heart syndrome. Overall operative mortality was 12.4% (26 of 209). s-CS2 had a lower prevalence of preoperative extracorporeal membrane oxygenation use (0.0% vs 7.7%, p = 0.02) and less frequently underwent concomitant tricuspid valve procedures at the time of the operation (1.1% vs 11.5%, p = 0.01) than nons-CS2. Postoperatively, the prevalence of any of six The Society of Thoracic Surgeons Congenital Heart Surgery Database major complications was higher in nons-CS2 than in s-CS2 (53.9% vs 23.0%, p < 0.01), including a higher prevalence of renal failure (7.7% vs 0.6%, p = 0.04) and postoperative extracorporeal membrane oxygenation use (46.2% vs 2.7%, p < 0.01). There were no other preoperative, operative, or postoperative differences between the two groups. CONCLUSIONS: Operative mortality associated with the CS2 procedure is substantial, especially for patients receiving extracorporeal membrane oxygenation support after CS2. No obvious modifiable variables were noted between patients who died and those who survived.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Cua CL, McConnell PI, Meza JM, et al. Hybrid Palliation: Outcomes After the Comprehensive Stage 2 Procedure. Ann Thorac Surg. 2017. PMID: 29273201. doi:10.1016/j.athoracsur.2017.11.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。